Literature DB >> 22173644

Aptameric molecular switch for cascade signal amplification.

Cuiping Ma1, Chunhui Zhao, Yujie Ge, Chao Shi.   

Abstract

BACKGROUND: High sensitivity of analysis is constantly in demand in biomedical research and clinical diagnosis. In recent years aptamer-based analytical methods have been developed for protein detection. We developed a cascade signal amplification strategy based on molecular switches and aptamers to improve protein detection.
METHODS: Our cascade signal amplification strategy based on molecular switches and aptamers consisted of 2 steps, including the recognition and the triggering of a polymerase reaction. The procedure was designed to simplify the analysis by detecting trace amounts of target isothermally, in real time, and in a homogeneous solution. We applied this method to measure thrombin in human serum samples.
RESULTS: This cascade signal amplification strategy exhibited a linear response in thrombin concentration from 0.3 to 10 nmol/L, with a detection limit of 1.7 × 10(-10) mol/L within 60 min. Results of the analysis of thrombin in human serum diluted 1:1 appeared to be linear, as was observed in buffer, in the tested concentration range of 0.3-10 nmol/L.
CONCLUSIONS: The aptameric sensor provides promising potential for detecting and screening trace concentrations of biomarkers in complex matrices for clinical applications.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22173644     DOI: 10.1373/clinchem.2011.173195

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  2 in total

1.  X-Aptamer Technology Identifies C4A and ApoB in Blood as Potential Markers for Schizophrenia.

Authors:  Consuelo Walss-Bass; Ganesh L R Lokesh; Elena Dyukova; David G Gorenstein; David L Roberts; Dawn Velligan; David E Volk
Journal:  Mol Neuropsychiatry       Date:  2018-10-10

2.  Aptamer-based microchip electrophoresis assays for amplification detection of carcinoembryonic antigen.

Authors:  Li Pan; Jingjin Zhao; Yong Huang; Shulin Zhao; Yi-Ming Liu
Journal:  Clin Chim Acta       Date:  2015-09-03       Impact factor: 3.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.